Influenza News and Research

Latest Influenza News and Research

The intranasal route of immunization may offer effective protection against SARS-CoV-2

The intranasal route of immunization may offer effective protection against SARS-CoV-2

FDA authorizes first COVID-19 test to detect COVID-19, influenza A and B

FDA authorizes first COVID-19 test to detect COVID-19, influenza A and B

New antiviral drug completely suppresses SARS-CoV-2 transmission within 24 hours

New antiviral drug completely suppresses SARS-CoV-2 transmission within 24 hours

N-Glycosylation sites may contribute to spike-mediated invasion by SARS-CoV-2

N-Glycosylation sites may contribute to spike-mediated invasion by SARS-CoV-2

Pomegranate extract could inhibit the virus that causes COVID-19

Pomegranate extract could inhibit the virus that causes COVID-19

A new potential COVID-19 vaccine candidate: YF-S0

A new potential COVID-19 vaccine candidate: YF-S0

Scientists detect a sarbecovirus phylogenetically related to SARS-CoV-2 from bats in Japan

Scientists detect a sarbecovirus phylogenetically related to SARS-CoV-2 from bats in Japan

Potential SARS-CoV-2 antiviral: Ionophore X-206 found to inhibit viral replication in cell cultures

Potential SARS-CoV-2 antiviral: Ionophore X-206 found to inhibit viral replication in cell cultures

Researchers uncover the role of protein in identifying common cold virus

Researchers uncover the role of protein in identifying common cold virus

Chinese woman still sheds SARS-CoV-2 over four months post-infection

Chinese woman still sheds SARS-CoV-2 over four months post-infection

COVID-19 restrictions have led to 86 percent drop in norovirus infections in US, finds study

COVID-19 restrictions have led to 86 percent drop in norovirus infections in US, finds study

Nucleic acid-hydrolyzing scFv 3D8 exhibits potent antiviral effects on SARS-CoV-2

Nucleic acid-hydrolyzing scFv 3D8 exhibits potent antiviral effects on SARS-CoV-2

What are the risks associated with human challenge trials for SARS-CoV-2 vaccine candidates?

What are the risks associated with human challenge trials for SARS-CoV-2 vaccine candidates?

Transmission 'hot zones' drive COVID-19 infection patterns, says study

Transmission 'hot zones' drive COVID-19 infection patterns, says study

Could the keto diet help prevent or mitigate severe COVID-19?

Could the keto diet help prevent or mitigate severe COVID-19?

Resveratrol shows potential as SARS-CoV-2 antiviral, study finds

Resveratrol shows potential as SARS-CoV-2 antiviral, study finds

Salient Bio launches robotics driven COVID-19 mass testing platform

Salient Bio launches robotics driven COVID-19 mass testing platform

COVID-19 may trigger recurrent Guillain–Barré Syndrome episodes, a case study shows

COVID-19 may trigger recurrent Guillain–Barré Syndrome episodes, a case study shows

SARS-CoV-2 immunity can sustain for at least eight months, study finds

SARS-CoV-2 immunity can sustain for at least eight months, study finds

Researchers develop synthetic defective SARS-CoV-2 genome that inhibits viral replication

Researchers develop synthetic defective SARS-CoV-2 genome that inhibits viral replication

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.